The Mouse Monoclonal anti-KRT20 antibody (Clone KRT20-1993) (ABIN7871725) specifically detects KRT20 in WB and IHC (p).
The antibody is reactive with Human samples.
KRT20
Reactivity: Human, Mouse, Rat
WB, IHC (p), IF (cc)
Host: Rabbit
Monoclonal
1F10
unconjugated
Application Notes
Optimal dilution of the CK20 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
1 mg/mL in 1X PBS, BSA free, sodium azide free
Preservative
Azide free
Storage
4 °C,-20 °C
Storage Comment
Store the CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Target
KRT20
(Keratin 20 (KRT20))
Alternative Name
CK20
Background
This mAb recognizes an intermediate filament protein of 46 kDa, identified as Cytokeratin 20 (KRT20, CK20). KRT is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.